RET-IN-1
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552, has IC50s of 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M), and RET (G810R), respectively [1].
Product Specifications
CAS Number
2222755-14-6
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-1.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=NC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(OC[C@H]7CNCCO7)=CN2N=C1
Molecular Formula
C29H31N9O3
Molecular Weight
553.61
References & Citations
[1]Steven W A, et al. Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors. WO2018071447A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E45H35151M5 20 µg
AMPK alpha 1 (PRKAA1) (NM_006251) Human Recombinant Protein
Sign In for Pricing
View Details 
K4467503 1.0 µg DNA
Orc2 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
MBS1406125-01 0.5 mg (E-Coli)
Recombinant Fowlpox virus Virion membrane protein A21 homolog (FPV186), partial
Sign In for Pricing
View Details MBS1406125-02 0.05 mg (Baculovirus)
Recombinant Fowlpox virus Virion membrane protein A21 homolog (FPV186), partial
Sign In for Pricing
View Details